Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine

Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine

Guang-dan Zhu,1 Eric Dawson,1 Angela Huskey,1 Ronald J Gordon,2 Andria L Del Tredici1 1Millennium Health, LLC, San Diego, CA, USA; 2Department of Anesthesiology, University of California, UC San Diego School of Medicine, La Jolla, CA, USACorrespondence:Andria L Del TrediciMillennium Health, LLC, 169...

Full description

Bibliographic Details
Main Authors: Zhu G, Dawson E, Huskey A, Gordon RJ, Del Tredici AL
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
succinylcholine
bche
genotyping
prolonged neuromuscular blockade
pharmacogenetics
Online Access:https://www.dovepress.com/genetic-testing-for-bche-variants-identifies-patients-at-risk-of-prolo-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/genetic-testing-for-bche-variants-identifies-patients-at-risk-of-prolo-peer-reviewed-article-PGPM

Similar Items